Addex Therapeutics

IPO

Allosteric modulators for human health

Public · Plan-les-Ouates, Switzerland · Founded 2002 · $155.9M raised

Headquarters
Plan-les-Ouates
Employees
11–50
Founded
2002
Business Model
B2B
Total Funding
$155.9M
Last Round
$900K Extension RoundAug 2022
Rounds
7
Type
Public

About

Addex Therapeutics is a clinical-stage biopharmaceutical company headquartered in Plan-les-Ouates, Geneva, Switzerland, focused on the discovery and development of novel orally available small molecule allosteric modulators for neurological disorders. The company's pipeline includes programs targeting mGlu5, mGlu2, mGlu7, and GABAB receptors for indications including post-stroke recovery, traumatic brain injury, substance use disorder, chronic cough, and anxiety-related disorders. Addex also launched a spin-out, Neurosterix, to advance M4 PAM allosteric modulators for schizophrenia. The company trades on SIX Swiss Exchange and has US ADRs listed.

Summary

Addex Therapeutics is a Biotech company based in Plan-les-Ouates, Switzerland, founded in 2002. It has raised $155.9M in total across 7 rounds, most recently a $900K Extension Round round in Aug 2022. Investors include Index Ventures, SR One and Roche.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Extension RoundPrivate PlacementAug 2022
$900K

Sign up to see all 8 rounds

Series A through Extension Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Addex Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/addex-therapeutics"><img src="https://indexed.vc/api/badge/company/addex-therapeutics" alt="Addex Therapeutics on Indexed.vc" width="260" height="76" /></a>